Biotechnology
Releases published in the last 30 days. 
Page 1 of 2
- Environmental Testing for Fentanyl and Other Illicit Drugs to Protect Emergency Responders
- 7/16/2019 11:57:00 AM
- In April, U.S. News & World Report published an article that claimed the Department of Homeland Security (DHS) had been considering classifying the drug fentanyl as a weapon of mass destruction.
- Sobi Invites Entries to First Sobi Scientific Innovation Awards
- 7/16/2019 8:55:09 AM
- Sobi™ has established the Sobi Scientific Innovation Awards, with a focus on the future of haemophilia care, to recognise innovation and scientific excellence in haemophilia research.
- Catholic University of Korea Seoul St. Mary’s Hospital and Philips team up to improve cancer diagnosis
- 7/12/2019 8:55:56 AM
- Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced successful implementation of its Philips IntelliSite Pathology Solution at the Catholic University of Korea Seoul St.
- Cyborg-like microchip valve driven by earthworm muscle
- 7/11/2019 12:11:50 PM
- For several decades, researchers have been trying to combine microelectromechanical systems (MEMS) with living material. Bio-MEMS have many applications, ranging from improved drug delivery and optical and electrochemical sensors to organs-on-chips.
- Expanding Business and Capital Alliance Contract with HEALIOS K.K. to develop practical applications for regenerative medicine
- 7/11/2019 11:49:47 AM
- Nikon Corporation (Nikon) agreed on the expansion of partnership between HEALIOS K.K. (Hardy TS Kagimoto, CEO, Tokyo, Japan, hereafter referred to as Healios) based on the business and capital alliance agreement concluded in 2017.
- Agilent to Acquire BioTek, Strengthening Leadership Position in Growing Cell Analysis Segment
- 7/11/2019 9:30:12 AM
- Highlights: • Combined portfolio enables Agilent to provide a more complete and integrated solution for customers in the important and fast-growing area of live cell analysis • BioTek is a recognized leader for plate-readers and imaging systems with complementary offerings to Agilent’s portfolio • Excellent growth potential; the acquisition positions Agilent well …
- International Commission on Clinical Use of Heritable Human Genome Editing to Hold Public Meeting Aug. 13 in Washington, D.C.
- 7/10/2019 4:27:36 PM
- The International Commission on the Clinical Use of Human Germline Genome Editing is holding its first public meeting on Aug. 13 in Washington, D.C.
- Mission Bio Launches in China, Announces Distribution Partnership with Novogene
- 7/10/2019 2:32:56 PM
- Mission Bio, the pioneer in targeted single-cell DNA analysis and precision genomics, today announced that it has launched sales in China through a distribution agreement with Novogene, a leading provider of genomic services and solutions globally.
- California Residents Learn How to Determine If Cockroach Allergens Are Present in Their Homes, Schools and Offices
- 7/10/2019 11:51:08 AM
- According to the University of California’s Agriculture and Natural Resources, there are six species of cockroaches in the state that can become pests.
- Eni and Coldiretti sign a Memorandum of Understanding for joint projects relating to the circular economy
- 7/8/2019 11:43:08 AM
- The President of the Confederazione Nazionale Coldiretti, Ettore Prandini, and the Chief Executive Officer of Eni, Claudio Descalzi, in the presence of the Minister of Economic Development, Labour and Social policies, Luigi Di Maio, have today signed a Memorandum of Understanding outlining key areas for collaboration with regards to the circular economy.
- TechnipFMC completes construction of the new Boehringer Ingelheim Respimat® plant in Spain
- 7/8/2019 10:36:10 AM
- TechnipFMC carried out the Engineering, Procurement and Construction Management (EPCM) for the expansion of the Boehringer Ingelheim facility, where the multinational pharmaceutical company has launched the Respimat® inhalation device production.
- Discovery of Mechanism Behind Precision Cancer Drug Opens Door for More Targeted Treatment
- 7/8/2019 9:32:23 AM
- New research that uncovers the mechanism behind the newest generation of cancer drugs is opening the door for better targeted therapy. PARP inhibitors are molecular targeted cancer drugs used to treat women with ovarian cancer who have the BRCA1 and BRCA2 gene mutations.
- Easing the Burden for People with Hemophilia
- 7/3/2019 1:39:38 PM
- As recently as five years ago, effectively managing hemophilia meant frequent therapy infusions to prevent uncontrolled bleeding, limitations on physical activities in order to guard against injury and, as adults, chronic and severe pain from accumulated joint damage that, in some cases, led to disability.
- Philips ships two-millionth AED, helping to save lives across the globe
- 7/3/2019 12:49:57 PM
- Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced shipment of its two-millionth AED (Automated External Defibrillator), which was delivered to a customer in Italy.
- New metalloenzyme-based system allows selective targeting of cancer cells
- 7/3/2019 10:51:31 AM
- In the field of organic synthetic chemistry, many metal catalysts have been developed with the capacity to synthesize molecules such as drugs and functional materials.
- Innate immune responses to high-fat diets lead to obesity
- 7/3/2019 10:07:35 AM
- Why is eating a high fat diet a recipe for obesity? According to a new study from the RIKEN Center for Integrative Medical Sciences (IMS) in Japan, the answer involves the activity of a specific type of immune cell that lives in the small intestine.
- Mark Scott awarded the Elsevier and Institut Cochin Innovation Award 2019
- 7/3/2019 9:59:53 AM
- The Institut Cochin, Paris Descartes Foundation and Elsevier, the information analytics business specializing in science and health, today awarded Mark Scott the third Elsevier-Institut Cochin Innovation prize for his work on the development of chemical modulators of tumor suppressor PTEN.
- Forxiga receives positive EU CHMP opinion for DECLARE-TIMI 58 cardiovascular outcomes data
- 7/2/2019 6:18:47 AM
- AstraZeneca announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended a change to the European marketing authorisation for Forxiga (dapagliflozin) in patients with type-2 diabetes (T2D) to include cardiovascular (CV) outcomes data from the Phase III DECLARE-TIMI 58 trial.
- Scott Gottlieb Elected to Pfizer’s Board of Directors
- 6/27/2019 7:29:49 PM
- Pfizer Inc. (NYSE:PFE) today announced the election of Dr. Scott Gottlieb to its Board of Directors, effective immediately. Dr. Gottlieb, age 47, was also appointed to the Regulatory and Compliance Committee and the Science and Technology Committee of Pfizer’s Board.
- Two Elementary Schools Reopen After Hazardous Chemicals Found Beneath Them
- 6/26/2019 11:55:07 AM
- Earlier this spring, WBAA, a news station, announced that two elementary schools in Indiana were reopening after the latest round of tests determined the indoor air quality was safe from hazardous chemicals that had been detected beneath the schools.
